Skip to main navigation Skip to search Skip to main content

Necrotizing vasculitis triggered by gefitinib: An unusual clinical presentation

Research output: Contribution to journalJournal Article peer-review

9 Scopus citations
Original languageAmerican English
JournalJournal of Clinical Oncology
Volume29
Issue number7
DOIs
StatePublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antineoplastic Agents/adverse effects
  • Antineoplastic Agents/therapeutic use
  • Biopsy, Needle
  • Carcinoma, Non-Small-Cell Lung/drug therapy
  • Carcinoma, Non-Small-Cell Lung/pathology
  • Carcinoma, Non-Small-Cell Lung/surgery
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Lower Extremity
  • Lung Neoplasms/drug therapy
  • Lung Neoplasms/pathology
  • Lung Neoplasms/surgery
  • Male
  • Middle Aged
  • Necrosis/chemically induced
  • Necrosis/drug therapy
  • Neoplasm Invasiveness/pathology
  • Neoplasm Staging
  • Prednisolone/administration & dosage
  • Quinazolines/adverse effects
  • Quinazolines/therapeutic use
  • Risk Assessment
  • Skin Diseases, Vascular/chemically induced
  • Skin Diseases, Vascular/drug therapy
  • Skin Diseases, Vascular/pathology
  • Treatment Outcome
  • Vasculitis/chemically induced
  • Vasculitis/drug therapy
  • Vasculitis/pathology

Cite this